Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

USNA Insider Trading

USANA HEALTH SCIENCES INC | Medicinal Chemicals & Botanical Products

Comprehensive Trading Performance Summary

The investment history of corporate insiders at USANA HEALTH SCIENCES INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Medicinal Chemicals & Botanical Products sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-12-11 19:25 2025-12-10 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $21.00 873 $18,333 8,387 -9.4%
2025-12-11 19:21 2025-12-10 Benedict Peter Officer - CHIEF INFORMATION OFFICER SELL $20.95 2,673 $56,001 0 -100.0%
2025-11-11 01:20 2025-11-10 Winssinger Frederic J Director SELL $19.21 2,000 $38,420 5,986 -25.0%
2025-11-04 19:28 2025-11-03 FULLER GILBERT A Director SELL $21.48 1,057 $22,704 0 -100.0%
2025-11-03 19:30 2025-10-31 Fleming John Turman Director SELL $19.79 1,750 $34,633 4,565 -27.7%
2025-08-08 21:22 2025-08-07 FULLER GILBERT A Director SELL $29.10 1,058 $30,789 0 -100.0%
2025-07-31 18:03 2025-07-30 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $30.26 3,515 $106,364 9,260 -27.5%
2025-06-10 19:35 2025-06-09 Fleming John Turman Director SELL $29.66 500 $14,829 4,200 -10.6%
2025-05-29 17:24 2025-05-27 Noot Walter Officer - CHIEF OPERATING OFFICER SELL $30.29 6,291 $190,568 0 -100.0%
2025-05-12 17:42 2025-05-09 IIEKKING G DOUG Officer - CHIEF FINANCIAL OFFICER SELL $29.61 4,548 $134,662 0 -100.0%
2025-05-06 22:34 2025-05-05 FULLER GILBERT A Director OPT+S $29.82 674 $20,101 0 0.0%
2025-03-13 19:36 2025-03-12 Foukas Joshua Officer - CHIEF LEGAL OFFICER SELL $32.54 5,732 $186,514 0 -100.0%
2025-03-13 19:23 2025-03-12 Neidig Brent Officer - CHIEF COMMERCIAL OFFICER SELL $32.34 4,743 $153,387 0 -100.0%
2025-03-12 20:05 2025-03-11 Fleming John Turman Director SELL $33.30 500 $16,648 4,026 -11.0%
2025-03-11 18:00 2025-03-10 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $32.98 3,234 $106,670 12,775 -20.2%
2025-03-10 18:33 2025-03-06 FULLER GILBERT A Director SELL $31.44 674 $21,190 0 -100.0%
2025-03-04 04:09 2025-03-03 Brown Jim Officer - CEO & PRESIDENT SELL $29.47 5,000 $147,350 15,716 -24.1%
2025-03-03 19:58 2025-02-27 Pelosi Peggie Director SELL $28.10 780 $21,918 3,395 -18.7%
2024-11-05 20:57 2024-11-04 FULLER GILBERT A Director OPT+S $37.71 675 $25,457 0 0.0%
2024-08-14 18:22 2024-08-13 Jones Paul A. Officer - CHIEF PEOPLE OFFICER SELL $38.38 6,266 $240,487 0 -100.0%
2024-08-08 19:06 2024-08-07 FULLER GILBERT A Director SELL $39.69 674 $26,753 0 -100.0%
2024-08-02 00:28 2024-07-31 Fleming John Turman Director SELL $44.43 1,000 $44,430 2,503 -28.5%
2024-06-15 03:32 2024-06-12 WENTZ MYRON W 10% owner SELL $45.42 15,698 $712,959 7,864,345 -0.2%
2024-06-12 04:56 2024-06-07 WENTZ MYRON W 10% owner SELL $48.61 3,700 $179,857 7,880,043 0.0%
2024-05-23 20:03 2024-05-22 Jones Paul A. Officer - CHIEF PEOPLE OFFICER SELL $48.66 2,714 $132,064 6,266 -30.2%
2024-05-08 02:43 2024-05-07 IIEKKING G DOUG Officer - CHIEF FINANCIAL OFFICER SELL $44.76 5,198 $232,677 0 -100.0%
2024-05-07 23:08 2024-05-07 FULLER GILBERT A Director SELL $44.59 490 $21,849 0 -100.0%
2024-05-02 23:18 2024-05-02 Macuga Daniel A. Officer - CHIEF COMMUNICATIONS OFFICER SELL $47.14 3,791 $178,717 0 -100.0%
2024-03-11 21:26 2024-03-11 Guest Kevin Officer - EXEC. CHAIRMAN OF THE BOARD SELL $49.00 11,011 $539,539 10,491 -51.2%
2024-03-11 21:22 2024-03-08 Noot Walter Officer - CHIEF OPERATING OFFICER SELL $49.05 5,240 $257,022 0 -100.0%
2024-03-07 19:50 2024-03-06 Neidig Brent Officer - CO. & MAN. DIR. OF CHINA SELL $47.00 3,810 $179,066 0 -100.0%
2024-03-06 02:28 2024-03-05 SINNOTT ROBERT A Officer - CHIEF SCIENTIFIC OFFICER SELL $46.56 3,945 $183,659 0 -100.0%
2024-03-05 20:36 2024-03-04 Fleming John Turman Director SELL $48.99 300 $14,696 3,013 -9.1%
2024-03-05 20:28 2024-03-04 FULLER GILBERT A Director SELL $49.07 491 $24,096 0 -100.0%
2024-03-05 00:40 2024-02-29 Pelosi Peggie Director SELL $48.15 485 $23,351 3,138 -13.4%
2024-03-04 20:11 2024-03-01 Macuga Daniel A. Officer - CHIEF COMMUNICATIONS OFFICER SELL $48.08 1,500 $72,120 3,791 -28.4%
2024-03-04 20:05 2024-02-29 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $47.76 4,311 $205,872 7,825 -35.5%
2024-03-04 19:58 2024-02-29 Foukas Joshua Officer - CHIEF LEGAL OFFICER SELL $47.91 4,847 $232,234 0 -100.0%
2023-12-14 22:07 2023-12-12 Fleming John Turman Director SELL $49.73 312 $15,515 2,822 -10.0%
2023-11-07 23:22 2023-11-03 FULLER GILBERT A Director SELL $46.01 490 $22,546 0 -100.0%
2023-08-18 21:36 2023-08-17 Winssinger Frederic J Director SELL $63.84 930 $59,372 1,703 -35.3%
2023-08-17 02:14 2023-08-15 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $65.34 2,159 $141,067 5,448 -28.4%
2023-08-15 18:58 2023-08-11 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $66.28 1,080 $71,585 7,607 -12.4%
2023-08-03 23:49 2023-08-01 FULLER GILBERT A Director SELL $64.43 265 $17,075 0 -100.0%
2023-08-01 20:44 2023-07-31 FULLER GILBERT A Director SELL $65.01 226 $14,693 265 -46.0%
2023-08-01 20:43 2023-07-31 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $65.00 3,354 $218,010 8,687 -27.9%
2023-07-31 17:07 2023-07-28 Jones Paul A. Officer - CHIEF PEOPLE OFFICER SELL $65.00 3,682 $239,330 3,353 -52.3%
2023-07-28 18:40 2023-07-27 Ding Xia Director SELL $65.60 606 $39,753 1,421 -29.9%
2023-06-16 19:07 2023-06-15 Mulham David Mulham Officer - CHIEF SALES OFFICER SELL $61.00 1,557 $94,977 12,041 -11.5%
2023-06-15 21:28 2023-06-14 Macuga Daniel A. Officer - CHIEF COMMUNICATIONS OFFICER SELL $62.88 2,234 $140,474 778 -74.2%
SHOW ENTRIES
1-50 OF 699

How to Interpret $USNA Trades

Not every insider transaction in USANA HEALTH SCIENCES INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $USNA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for USNA

Insider activity data for USANA HEALTH SCIENCES INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $USNA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.